vs
Side-by-side financial comparison of Axsome Therapeutics, Inc. (AXSM) and Life360, Inc. (LIF). Click either name above to swap in a different company.
Axsome Therapeutics, Inc. is the larger business by last-quarter revenue ($196.0M vs $146.0M, roughly 1.3× Life360, Inc.). Life360, Inc. runs the higher net margin — 88.8% vs -14.6%, a 103.4% gap on every dollar of revenue. On growth, Axsome Therapeutics, Inc. posted the faster year-over-year revenue change (65.0% vs 26.4%). Life360, Inc. produced more free cash flow last quarter ($36.6M vs $-18.7M). Over the past eight quarters, Axsome Therapeutics, Inc.'s revenue compounded faster (61.7% CAGR vs 36.6%).
Jazz Pharmaceuticals plc is a global biopharmaceutical company with a focus on oncology and neuroscience. It was founded in 2003 in California, United States and is now headquartered in Dublin, Ireland.
Life360, Inc. develops family-focused safety and connectivity platforms. Core offerings include real-time location sharing, emergency alerts, driving behavior analysis tools and identity theft protection. It serves consumer markets across North America, Europe and Asia-Pacific, with most revenue from tiered premium subscription plans.
AXSM vs LIF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $196.0M | $146.0M |
| Net Profit | $-28.6M | $129.7M |
| Gross Margin | — | 75.1% |
| Operating Margin | -13.8% | 6.1% |
| Net Margin | -14.6% | 88.8% |
| Revenue YoY | 65.0% | 26.4% |
| Net Profit YoY | 61.9% | 1425.9% |
| EPS (diluted) | $-0.55 | $1.53 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $196.0M | $146.0M | ||
| Q3 25 | $171.0M | $124.5M | ||
| Q2 25 | $150.0M | $115.4M | ||
| Q1 25 | $121.5M | $103.6M | ||
| Q4 24 | $118.8M | $115.5M | ||
| Q3 24 | $104.8M | $92.9M | ||
| Q2 24 | $87.2M | $84.9M | ||
| Q1 24 | $75.0M | $78.2M |
| Q4 25 | $-28.6M | $129.7M | ||
| Q3 25 | $-47.2M | $9.8M | ||
| Q2 25 | $-48.0M | $7.0M | ||
| Q1 25 | $-59.4M | $4.4M | ||
| Q4 24 | $-74.9M | $8.5M | ||
| Q3 24 | $-64.6M | $7.7M | ||
| Q2 24 | $-79.3M | $-11.0M | ||
| Q1 24 | $-68.4M | $-9.8M |
| Q4 25 | — | 75.1% | ||
| Q3 25 | — | 78.0% | ||
| Q2 25 | — | 78.4% | ||
| Q1 25 | — | 80.6% | ||
| Q4 24 | — | 74.0% | ||
| Q3 24 | — | 75.4% | ||
| Q2 24 | — | 75.0% | ||
| Q1 24 | — | 76.7% |
| Q4 25 | -13.8% | 6.1% | ||
| Q3 25 | -27.0% | 4.6% | ||
| Q2 25 | -24.5% | 1.7% | ||
| Q1 25 | -46.9% | 2.1% | ||
| Q4 24 | -61.1% | 4.9% | ||
| Q3 24 | -59.8% | -5.3% | ||
| Q2 24 | -89.5% | -2.8% | ||
| Q1 24 | -89.7% | -8.2% |
| Q4 25 | -14.6% | 88.8% | ||
| Q3 25 | -27.6% | 7.9% | ||
| Q2 25 | -32.0% | 6.1% | ||
| Q1 25 | -48.9% | 4.2% | ||
| Q4 24 | -63.1% | 7.4% | ||
| Q3 24 | -61.7% | 8.3% | ||
| Q2 24 | -91.0% | -12.9% | ||
| Q1 24 | -91.1% | -12.5% |
| Q4 25 | $-0.55 | $1.53 | ||
| Q3 25 | $-0.94 | $0.11 | ||
| Q2 25 | $-0.97 | $0.08 | ||
| Q1 25 | $-1.22 | $0.05 | ||
| Q4 24 | $-1.54 | $0.14 | ||
| Q3 24 | $-1.34 | $0.09 | ||
| Q2 24 | $-1.67 | $-0.15 | ||
| Q1 24 | $-1.44 | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $322.9M | $494.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.3M | $548.2M |
| Total Assets | $689.8M | $959.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $322.9M | $494.3M | ||
| Q3 25 | $325.3M | $455.7M | ||
| Q2 25 | $303.0M | $432.7M | ||
| Q1 25 | $300.9M | $168.9M | ||
| Q4 24 | $315.4M | $159.2M | ||
| Q3 24 | $327.3M | $159.0M | ||
| Q2 24 | $315.7M | $160.8M | ||
| Q1 24 | $331.4M | $73.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $5.2M |
| Q4 25 | $88.3M | $548.2M | ||
| Q3 25 | $73.7M | $391.4M | ||
| Q2 25 | $73.1M | $366.7M | ||
| Q1 25 | $53.2M | $376.3M | ||
| Q4 24 | $57.0M | $358.5M | ||
| Q3 24 | $92.9M | $339.7M | ||
| Q2 24 | $102.9M | $326.7M | ||
| Q1 24 | $144.0M | $239.8M |
| Q4 25 | $689.8M | $959.7M | ||
| Q3 25 | $669.3M | $787.5M | ||
| Q2 25 | $639.8M | $753.6M | ||
| Q1 25 | $596.7M | $455.4M | ||
| Q4 24 | $568.5M | $441.6M | ||
| Q3 24 | $561.5M | $427.4M | ||
| Q2 24 | $548.2M | $405.9M | ||
| Q1 24 | $545.7M | $318.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-18.7M | $36.8M |
| Free Cash FlowOCF − Capex | $-18.7M | $36.6M |
| FCF MarginFCF / Revenue | -9.6% | 25.1% |
| Capex IntensityCapex / Revenue | 0.0% | 0.2% |
| Cash ConversionOCF / Net Profit | — | 0.28× |
| TTM Free Cash FlowTrailing 4 quarters | $-93.9M | $86.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-18.7M | $36.8M | ||
| Q3 25 | $1.0M | $26.4M | ||
| Q2 25 | $-32.4M | $13.3M | ||
| Q1 25 | $-43.4M | $12.1M | ||
| Q4 24 | $-26.2M | $12.3M | ||
| Q3 24 | $-18.6M | $6.3M | ||
| Q2 24 | $-30.1M | $3.3M | ||
| Q1 24 | $-53.5M | $10.7M |
| Q4 25 | $-18.7M | $36.6M | ||
| Q3 25 | $988.0K | $25.6M | ||
| Q2 25 | $-32.4M | $12.7M | ||
| Q1 25 | $-43.7M | $11.9M | ||
| Q4 24 | $-26.2M | $11.2M | ||
| Q3 24 | $-18.7M | $6.3M | ||
| Q2 24 | $-30.2M | $3.2M | ||
| Q1 24 | $-53.6M | — |
| Q4 25 | -9.6% | 25.1% | ||
| Q3 25 | 0.6% | 20.6% | ||
| Q2 25 | -21.6% | 11.0% | ||
| Q1 25 | -36.0% | 11.5% | ||
| Q4 24 | -22.1% | 9.7% | ||
| Q3 24 | -17.9% | 6.8% | ||
| Q2 24 | -34.6% | 3.8% | ||
| Q1 24 | -71.4% | — |
| Q4 25 | 0.0% | 0.2% | ||
| Q3 25 | 0.0% | 0.6% | ||
| Q2 25 | 0.0% | 0.6% | ||
| Q1 25 | 0.3% | 0.1% | ||
| Q4 24 | 0.0% | 1.0% | ||
| Q3 24 | 0.1% | 0.0% | ||
| Q2 24 | 0.1% | 0.1% | ||
| Q1 24 | 0.1% | 0.0% |
| Q4 25 | — | 0.28× | ||
| Q3 25 | — | 2.70× | ||
| Q2 25 | — | 1.90× | ||
| Q1 25 | — | 2.75× | ||
| Q4 24 | — | 1.45× | ||
| Q3 24 | — | 0.83× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
